MktsMarkets

agilon health, inc.
NYSE: AGLKey statistics
AGL News
Stories mentioning AGL from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 1,420,460 | 1,569,491 | 1,435,321 | 1,394,982 | 1,532,782 | 1,522,486 | 1,450,932 | 1,482,758 |
| Cost of Goods Sold | ||||||||
| Gross Profit | ||||||||
| Operating Expenses | ||||||||
| Research & Development | ||||||||
| Sales General & Admin | ||||||||
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | 3,997 | (193,825) | (131,274) | (116,027) | (22,110) | (108,100) | (133,508) | (43,344) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | ||||||||
| Pretax Income | 29,944 | (187,558) | (110,538) | (104,308) | (1,692) | (104,673) | (117,022) | (30,245) |
| Tax Provision | 28.00 | 1,324 | (331.00) | 62.00 | 196.00 | 1,757 | (590.00) | 417.00 |
| Net Income (Loss) | 48,916 | (188,882) | (110,207) | (104,370) | 12,112 | (105,790) | (117,615) | (30,682) |
| Earnings Per Share (Basic) | 2.95 | (0.46) | 0.73 | (0.26) | ||||
| Earnings Per Share (Diluted) | 2.94 | (0.46) | 0.73 | (0.26) | ||||
| Weighted Average Shares Outstanding (Basic) | 16,599 | 413,969 | 414,465 | 413,836 | 16,517 | 410,966 | 411,591 | 411,271 |
| Weighted Average Shares Outstanding (Diluted) | 16,662 | 413,969 | 414,465 | 413,836 | 16,517 | 410,966 | 411,591 | 411,271 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About AGL
agilon health, inc. (NYSE: AGL) is a stock listed on the New York Stock Exchange under the ticker symbol AGL. It last traded at $113.52 (Nov 10, 2026, 4:00 PM ET), down 0.4% on the day. That gives agilon health a market capitalisation of $1.9B.
Over the past 52 weeks AGL has traded between $7.48 and $133.04.
Revenue for the quarter ended Mar 31, 2026 was $1.4B; net income $48.9M. Revenue was down 7.3% from $1.5B in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $1.4B | $48.9M | 3.4% |
| Dec 31, 2025 | $1.6B | -$188.9M | -12.0% |
| Sep 30, 2025 | $1.4B | -$110.2M | -7.7% |
| Jun 30, 2025 | $1.4B | -$104.4M | -7.5% |
From agilon health’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…